SUBSEQUENT EVENTS (Details) $ in Millions					12 Months Ended
	Feb. 22, 2024 USD ($)	Feb. 15, 2024 shares	Feb. 14, 2024 shares	Dec. 12, 2023 USD ($)	Dec. 31, 2023 USD ($) shares	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($) shares	Feb. 27, 2024 USD ($)	Feb. 16, 2024 CAD ($)	Feb. 16, 2024 USD ($)	Jan. 24, 2024 USD ($) shares
Subsequent Event [Line Items]
Payments on contingent consideration | $					$ 12,500,000	$ 0	$ 0
Restricted Stock
Subsequent Event [Line Items]
Shares granted (in shares)					674,000	748,000	541,000
Performance Shares
Subsequent Event [Line Items]
Shares granted (in shares)					85,000
Vesting period					3 years
Subsequent Event | CG Oncology, Inc.
Subsequent Event [Line Items]
Investment, cost | $											$ 19
Shares held (in shares)											219,925
Value of shares held | $								$ 10,200,000			$ 0
Subsequent Event | Oakville, Ontario Former Manufacturing Facility | Disposal Group, Held-for-Sale, Not Discontinued Operations
Subsequent Event [Line Items]
Consideration									$ 19.2	$ 14,200,000
First purchase price deposit									$ 1.0	$ 700,000
Subsequent Event | Restricted Stock
Subsequent Event [Line Items]
Shares granted (in shares)			525,729
Vesting period		4 years	4 years
Subsequent Event | Restricted Stock | New Employees
Subsequent Event [Line Items]
Shares granted (in shares)		13,054
Subsequent Event | Performance Shares
Subsequent Event [Line Items]
Shares granted (in shares)			73,588
Vesting period			3 years
Performance period			3 years
Subsequent Event | Performance Shares | Officer
Subsequent Event [Line Items]
Shares granted (in shares)			66,433
Novitium
Subsequent Event [Line Items]
Payments on contingent consideration | $				$ 12,500,000
Novitium | Subsequent Event
Subsequent Event [Line Items]
Payments on contingent consideration | $	$ 12,500,000